Trisykliske aminderivater som proteintyrosinkinase inhibitorer

Det beskrives nye bisykliske, heterosykliske derivatforbindelser. Det beskrives videre farmasøytiske preparater omfattende disse forbindelser og anvendelse av forbindelsene ved behandling av sykdommer, for eksempel cancer. The invention relates to new bicyclic heterocyclic derivative compounds of Fo...

Full description

Saved in:
Bibliographic Details
Main Authors Saxty, Gordon, Besong, Gilbert Ebai, Carr, Maria Grazia, Madin, Andrew, Taylor, Richard David, Griffiths-Jones, Charlotte Mary, Pike, Andrew, Nijjar, Rajdeep Kaur, Vickerstaffe, Emma, Congreve, Miles Stuart, Callaghan, Owen, Berdini, Valerio, O'Brien, Michael Alistair, Gill, Adrian Liam, Murray, Christopher William
Format Patent
LanguageNorwegian
Published 20.08.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Det beskrives nye bisykliske, heterosykliske derivatforbindelser. Det beskrives videre farmasøytiske preparater omfattende disse forbindelser og anvendelse av forbindelsene ved behandling av sykdommer, for eksempel cancer. The invention relates to new bicyclic heterocyclic derivative compounds of Formula (I), to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer. The compounds of Formula (I) are inhibitors of FGFR, VEGFR or PDGFR.
Bibliography:Application Number: NO20090002658